The Council is pleased to announce the appointment of Dr. Stuart MacLeod as Chair of the Expert Panel on the State of Therapeutic Products for Children. In December 2011 Health Canada requested that the Council conduct an in-depth, evidence-based assessment of therapeutic products for children.
As Chair of the Council’s Expert Panel, Dr. MacLeod will work with a multidisciplinary group of experts, to be appointed by the Council, to address the following question: What is the state of clinical pharmacology, in Canada and abroad, that can be applied to the ethical development of safe and effective pharmaceuticals and biologics labelled as therapies for infants, children and youth?
Dr. MacLeod is currently Professor of Pediatrics, Faculty of Medicine, at the University of British Columbia. He was Director of the Child and Family Research Institute at British Columbia Children’s Hospital and Associate Dean of Research at UBC until January 2010. He was also Vice President Research Coordination and Academic Liaison for the Provincial Health Services Authority of British Columbia until August 2012.
Dr. MacLeod is recognized internationally for his work in drug therapy and has served two terms as chair of the Canadian Pediatric Society’s Committee on Drugs and Hazardous Substances and was also seconded to the American Academy of Pediatrics Committee on Drugs. He is a fellow of the Canadian Academy of Health Sciences, as well as the Royal Colleges of Physicians of Edinburgh and Glasgow.
The Council, under the guidance of its Scientific Advisory Committee, is now assembling an expert panel to complete its assessment on therapeutic products for children. The panel will consist of experts from a wide range of disciplines and backgrounds to ensure the most authoritative, credible, and independent response to the question.
For continued updates on the status of the assessment visit the Therapeutic Products for Children page.